Abstract
Over a decade has passed since the initial observation that neutral platinum amine coordination compounds with cis configuration of labile groups were effective chemotherapeutic agents.1 Subsequent studies built a strong case that DNA is the relevant biological target of these complexes.2,3 Substantial effort has therefore been directed towards defining and characterizing the interactions of cis-Pt(NH3)2Cl2 (cis-DDP) and the inactive trans-Pt(NH3)2Cl2 (trans-DDP),4 the structures of which are shown in Figure 1, with DNA at the molecular level.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Rosenberg, B.; Van Camp, L.; Trosko, J.E.; Mansour, V.H. Nature (London) 222 (1969), 385–386.
Roberts, J.J. Advances in Inorganic Biochemistry, Ed., Eichhorn, G.L.; Marzilli, L.G. Elsevier, 1981, p. 273–332.
Roberts, J.J.; Pera, Jr., M.F. Platinum, Gold and Other Metal Chemotherapeutic Agents, ACS Symposium Series #209, Ed., Lippard, S.J. p. 3–25.
Prestayko, A.W.; Crooke, S.K.; Carter, S.H. Cisplatin, Current Status and New Developments; Eds., Prestayko, A.W.; Crooke, S.T.; Carter, S.K., Academic Press, 1980.
Howe-Grant, M.; Wu, K.C.; Bauer, W.R.; Lippard, S.J. Biochemistry 15 (1976), 4339–4346.
Pascoe, J.M.; Roberts, J.J. Biochem. Pharmacol. 23 (1974), 1345–1357.
Roberts, J.J.; Friedlos, F. Biochim. Biophys. Acta 655 (1981), 146–151.
Pera, M.F.; Rawlings, C.J.; Shackleton, J.; Roberts, J.J. Biochim. Biophys. Acta 655 (1981), 152–156.
Stone, P.J.; Kelman, A.D.; Sinex, F.M. J. Mol. Biol. 104 (1976), 793–801.
Zwelling, L.A.; Michaels, S.; Schwartz, H.; Dobson, P.P.; Kohn, K.W. Cancer Res. 41 (1981), 640–649.
Laurent, G.; Erickson, L.C.; Sharkey, N.A.; Kohn, K.W. Cancer Res. 41 (1981), 3347–3351.
Strandberg, M.C. Proc. Amer. Assoc. Cancer Res. 22 (1981), 202, A799.
Shooter, K.V.; Howse, R.; Merrifield, R.K.; Robbins, A.B. Chem.-Biol. Interact. 5 (1972), 289–307.
Filipski, J.; Kohn, K.W.; Bonner, W.M. Chem.-Biol. Interact. 32 (1980), 321–330.
Ushay, H.M.; Tullius, T.D.; Lippard, S.J. Biochemistry 20 (1981), 3744–3748.
Cohen, G.L.; Ledner, J.A.; Bauer, W.R.; Ushay, H.M.; Caravana, C.; Lippard, S.J. J. Am. Chem. Soc. 102 (1980), 2487–2488.
Tullius, T.D.; Lippard, S.J. J. Am. Chem. Soc. 103 (1981), 4620–4622.
Kelman, A.D.; Buchbinder, M. Biochimie 60 (1978), 893–899.
Brouwer, J.; van de Putte, P.; Fichtinger-Schepman, A.M.J.; Reedijk, J. Proc. Natl. Acad. Sci. USA 78 (1981), 7010–7014.
Caradonna, J.P.; Lippard, S.J.; Singh, M.; Gait, M. J. Am. Chem. Soc. 104 (1982), 5793–5795.
Tullius, T.D.; Ushay, H.M.; Merkel, C.M.; Caradonna, J.P.; Lippard, S.J. Platinum, Gold and Other Metal Chemotherapeutic Agents, Ed., Lippard, S.J. ACS Symposium Series #209, p. 51-71.
Tullius, T.D.; Lippard, S.J. Proc. Natl. Acad. Sci. USA 79 (1982), 3489–3492.
Poirier, M.C; Lippard, S.J.; Zwelling, L.A.; Ushay, H.M.; Kerrigan, D.; Thill, C.C.; Santella, R.M.; Grunberger, D.; Yuspa, S.H. Proc. Natl. Acad. Sci. USA 79 (1982), 6443–6447.
Lippard, S.J.; Ushay, H.M.; Merkel, C.M.; Poirier, M.C., Biochemistry (in press).
Lippard, S.J. Accounts Chem. Res. 11 (1978), 211–217.
Cohen, G.L.; Bauer, W.R.; Barton, J.K.; Lippard, S.J. Science 203 (1979), 1014–1016.
Mong, S.; Prestayko, A.W.; Crooke, S.T. in Cisplatin, Current Status and New Developments; Eds., Prestayko, A.W.; Crooke, S.T.; Carter, S.K., Academic Press, 1980, p. 213-226.
Lomonossoff, N.G.P.; Butler, P.J.G.; Klug, A. J. Mol. Biol. 149 (1981), 745–760.
Royer-Pokora, B.; Gordon, L.K.; Haseltine, W.A. Nucleic Acids Res. 9 (1981), 4595–4609.
Mansy, S.; Chu, G.Y.H.; Duncan, R.E.; Tobias, R.S. J. Am. Chem. Soc. 100 (1978), 607–616.
Howe-Grant, M.E.; Lippard, S.J. Met. Ions. Biol. Syst. 11 (1980), 63 and references cited therein.
Chottard, J.C.; Girault, J.P.; Chottard, G.; Lellemand, J.Y.; Mansuy, D. Nouv. J. Chim. 2 (1980), 551–553; (b) Chottard, J.C.; Girault, J.P.; Chottard, G.; Lellemand, J.Y.; Mansuy, D. J. Am. Chem. Soc. 102 (1980), 5565-5572; (c) Girault, J.P.; Chottard, C.; Lellemand, J.Y.; Chottard, J.C. Biochemistry 21 (1982), 1352-1356.
Marcelis, A.T.M.; Canters, G.W.; Reedijk, J. Recl. Trav. Chim. Pays-Bas. 100 (1981), 391–392.
Wang, J.C. J. Mol. Biol. 89 (1974), 783–801.
Mascharak, P.K.; Kuwahara, J.; Suzuki, T.; Sugiura, Y.; Lippard, S.J., submitted for publication.
Davis, Jr. H.L.; van Hoff, D.D.; Henney, J.E.; Rozencweig, M. Cancer Chemther. Pharmacol. 1 (1978), 83–90.
Umezawa, H. Bleomycin: Current Status and New Developments, Eds., Carter, S.K.; Crooke, S.T.; Umezawa, H.; Academic Press, 1978, p. 15ff.
Zwelling, L.A.; Kohn, K.W.; Ross, W.E.; Ewig, R.A.C.; Anderson, T. Cancer Res. 38 (1978), 1762–1786.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Martinus Nijhoff Publishing, Boston
About this chapter
Cite this chapter
Caradonna, J.P., Lippard, S.J. (1984). Chemical and Biological Studies of cis — Diamminedichloroplatinum (II) Binding to DNA. In: Hacker, M.P., Douple, E.B., Krakoff, I.H. (eds) Platinum Coordination Complexes in Cancer Chemotherapy. Developments in Oncology, vol 17. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2837-7_3
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2837-7_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-89838-619-6
Online ISBN: 978-1-4613-2837-7
eBook Packages: Springer Book Archive